FDA NDC Directory · JSON-LD · Markdown

VELCADE

NDC 63020-049 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namebortezomib
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021602
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsBORTEZOMIB (3.5 mg/1)
Marketing started20030513
Package count1

External sources

Source: openFDA. Public-domain (CC0).